title: Translational experimental therapeutics: The translation of laboratory-based discovery into disease-related therapy.
abstract: In the past decade, there has been an increasing emphasis on laboratory-based translational research. This has led to significant scientific advances in our understanding of disease mechanisms and in the development of novel approaches to therapy such as gene therapy, RNA interference, and stem cells. However, the translation of these remarkable scientific achievements into new and effective disease-modifying therapies has lagged behind these scientific accomplishments. We use the term "translational experimental therapeutics" to describe the pathway between the discovery of a basic disease mechanism or novel therapeutic approach and its translation into an effective treatment for patients with a specific disease. In this article, we review the components of this pathway, and discuss issues that might impede this process. Only by optimizing this pathway can we realize the full therapeutic potential of current scientific discoveries and translate the astounding advances that have been accomplished in the laboratory into effective treatments for our patients.
authors.affiliation: Neurology Department, University of Rochester Medical Center, Rochester, New York 14620, USA. karl.kieburtz@ctcc.rochester.edu
authors.forename: Karl
authors.initials: K
authors.lastname: Kieburtz
authors.forename: C Warren
authors.initials: CW
authors.lastname: Olanow
mesh_terms: D000818:Animals; D035843:Biomedical Research; D002986:Clinical Trials as Topic; D004353:Drug Evaluation, Preclinical; D006801:Humans; D023421:Models, Animal; D021841:Safe Sex; D013812:Therapeutics